References
- Ruffini F, Chojnacki A, Weiss S, Antel JP. Immunobiology of oligodendrocytes in multiple sclerosis. Adv Neurol 2006;98:47–63.
- Victor FL, Gottlieb AB, Menten A. Changing paradigms in dermatology: tumor necrosis factor alpha blockade in psoriasis and psoriatic arthritis. Clin Dermatol 2003;21:392–7.
- Robak T, Gladalska A, Stepieс H. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis. Eur Cytokine Netw 1998;9:145–54.
- Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907–16.
- Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003;74:391–401.
- Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J, et al. Circulating tumour necrosis factor alpha and soluble tumour necrosis factor receptors in patients with different patterns of rheumatoid synovitis. Ann Rheum Dis 2003;62:472–5.
- Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003;10:45–65.
- Kollias G. TNF pathophysiology in murine models of chronic inflammation and autoimmunity. Semin Arthritis Rheum 2005;34:3–6.
- Jeffes EWB, Ininns EK, Schmitz KL, Yamamoto RS, Dett CA, Granger GA. The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serum. Arthritis Rheum 1989;32:1148–52.
- Sennikov SV, Golikova EA, Kireev FD, Lopatnikova JA. Purification of human immunoglobulin G autoantibodies to tumor necrosis factor using affinity chromatography and magnetic separation. J Immunol Methods 2013;390:92–8.
- Wascher TC, Hermann J, Brezinschek R, Brezinschek HP, Wilders-Truschnig M, Rainer F, et al. Serum levels of interleukin-6 and tumour-necrosis-factor-alpha are not correlated to disease activity in patients with rheumatoid arthritis after treatment with low-dose methotrexate. Eur J Clin Invest 1994;24:73–5.
- Caсete JD, Albaladejo C, Hernandez MV, Lainez B, Pinto JA, Ramirez J, et al. Clinical significance of high levels of soluble tumour necrosis factor-α receptor-2 produced by alternative splicing in rheumatoid arthritis: a longitudinal prospective cohort study. Rheumatology 2011;50:721–8.
- Puel A, Doffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 2010;15;291–7.
- Maran R, Dueymes M, Le Corre R, Renaudineau Y, Shoenfeld Y, Youinou P. IgG subclasses of human autoantibodies. Ann Med Interne (Paris) 1997;148:29–38.